Alvin S. Parven, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 36,925 shares at $139.49 ($5.1M) on 2017-01-05, disclosed to the SEC on 2017-01-09.
Seasonal sale ($5.1M) by Director — this insider has traded ALXN in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.65 | 853 | $114K | 2.2% |
| 2 | $133.65 | 853 | $114K | 2.2% |
| 3 | $135.70 | 369 | $50K | 1.0% |
| 4 | $135.70 | 369 | $50K | 1.0% |
| 5 | $137.56 | 7,375 | $1.0M | 19.8% |
| 6 | $137.56 | 599 |
| $82K |
| 1.6% |
| 7 | $137.56 | 599 | $82K | 1.6% |
| 8 | $138.60 | 5,176 | $717K | 14.0% |
| 9 | $138.60 | 5,176 | $717K | 14.0% |
| 10 | $138.60 | 421 | $58K | 1.1% |
| 11 | $138.60 | 421 | $58K | 1.1% |
| 12 | $139.49 | 5,350 | $746K | 14.6% |
| 13 | $139.49 | 5,350 | $746K | 14.6% |
| 14 | $139.49 | 435 | $61K | 1.2% |
| 15 | $139.49 | 435 | $61K | 1.2% |
| 16 | $140.59 | 1,433 | $201K | 3.9% |
| 17 | $140.59 | 1,433 | $201K | 3.9% |
| 18 | $141.23 | 278 | $39K | 0.8% |
| Total | $138.52 avg | 36,925 | $5.1M | 100% |
| Filing → |
| ALXN | SELL | 2017-01-09 | $2.0M | — | Filing → |
| ALXN | SELL | 2016-08-24 | $2.1M | — | Filing → |
| ALXN | SELL | 2015-11-04 | $160K | — | Filing → |